Kodiak Sciences Inc..
biotech company
- Reports this week
- 0
- Active events
- 0
- Connections
- 26
What's happening
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
Kodiak Sciences Inc. trades shares on Nasdaq and receives average rating data from MarketBeat.Some support2 reports
-
Kodiak Sciences Inc. stock is listed on the Nasdaq exchange.Some support2 reports
-
Kodiak Sciences Inc. is developing therapeutics for MESI patients and presented Phase 1b APEX data at scientific meetings in France and Chicago.Some support4 reports1 development inside
-
Jim Cramer commented on Kodiak Sciences Inc. (KOD) during a lightning round regarding the impact of tariffs.Some support1 report
-
Kodiak Sciences Inc. was listed in a US penny stocks screener on July 11, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Kodiak Sciences Inc. this week
News at the entities that move Kodiak Sciences Inc. most-
Nasdaq StructuralFDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.Moves Kodiak Sciences Inc.
-
Jefferies Financial Group Mentioned togetherGap Inc. filed with the SEC regarding institutional investment activity, and Jefferies downgraded its stock rating and target price.Moves Kodiak Sciences Inc.
-
APEX StructuralApex Stegosaurus and Gus T. rex were sold at Sotheby's on November 4, 2026.Moves Kodiak Sciences Inc.
-
MarketBeat Mentioned togetherRoyal Bank of Canada reaffirmed an outperform rating for Visa Inc., with average rating data provided by MarketBeat.Moves Kodiak Sciences Inc.
-
New Orleans Shared contextMayor Helena Moreno proposed an infrastructure fee for the city of New Orleans, alongside reports on local employment.Moves Kodiak Sciences Inc.
Connections
The 10 strongest of 26, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Nasdaq Structural
Kodiak Sciences Inc. is a publicly traded company listed on the Nasdaq stock exchange.
-
MESI Operational
Kodiak Sciences is actively developing therapeutics and treatments specifically aimed at addressing MESI.
-
APEX Structural
Kodiak Sciences utilizes APEX's platform and data for its clinical trials and study enrollment.
-
Baker Transactional
Baker purchased shares of Kodiak Sciences stock on October 19, 2026.
-
Jefferies Financial Group Mentioned together
Jefferies Financial Group reiterated a buy rating on Kodiak Sciences Inc.
-
MarketBeat Mentioned together
MarketBeat provides average stock ratings and data for Kodiak Sciences Inc.
-
Daybreak Mentioned together
Kodiak Sciences reports results derived from a study conducted by Daybreak.
-
Palo Alto Shared context
Kodiak Sciences Inc. is headquartered in Palo Alto, California.
Show all 10 connections
-
PEAK Mentioned together
Kodiak Sciences is currently forecasting the availability of relevant data from PEAK in 2026/2027.
-
New Orleans Shared context
The evidence places a general industry meeting in New Orleans, providing only positional context.
History
Events by the month they beganOctober 2026
2 eventsSeptember 2026
1 eventJune 2026
5 events- Kodiak Sciences Inc. trades shares on Nasdaq and receives average rating data from MarketBeat.
- Kodiak Sciences Inc. stock is listed on the Nasdaq exchange.
- Kodiak Sciences Inc. is developing therapeutics for MESI patients and presented Phase 1b APEX data at scientific meetings in France and Chicago.
- Jim Cramer commented on Kodiak Sciences Inc. (KOD) during a lightning round regarding the impact of tariffs.
- Kodiak Sciences Inc. was listed in a US penny stocks screener on July 11, 2025.